| Literature DB >> 31528529 |
Nqobile Ndadane1, Roshen Chathram Maharaj1.
Abstract
INTRODUCTION: Sepsis is one of the leading causes of death worldwide. There is a paucity of data describing the epidemiology of sepsis in emergency centres in developing countries. This study aims to describe the clinical profile and management of patients presenting with sepsis in this setting.Entities:
Keywords: Developing countries; Emergency department; Sepsis
Year: 2019 PMID: 31528529 PMCID: PMC6742595 DOI: 10.1016/j.afjem.2019.02.001
Source DB: PubMed Journal: Afr J Emerg Med ISSN: 2211-419X
Fig. 1Breakdown of study sampling.
EC, emergency centre; SSC, Surviving Sepsis Campaign.
Sample demographic data.
| Variable | n (%) |
|---|---|
| Male/female | 18 (34.6)/34 (65.4) |
| 11–18 years | 1 (1.9) |
| 19–35 years | 20 (38.5) |
| 36–59 years | 24 (46.1) |
| >60 years | 7 (13.5) |
| HIV positive/negative/unknown | 32 (61.5)/4 (7.7)/16 (30.8) |
| HIV positive on ARVs | 16 (50) |
| Diabetes | 6 (11.5) |
| Tuberculosis | 10 (19.2) |
| Hypertension | 8 (15.0) |
| Epilepsy | 1 (1.9) |
| Stroke | 3 (5.7) |
| Asthma | 3 (5.7) |
HIV, human immunodeficiency virus; ARVs, anti-retroviral drugs.
Clinical presentation and laboratory results.
| Variable | Mean (±standard deviation) | Sample range |
|---|---|---|
| Respiratory rate (breaths/min) | 23.30 ± 4.89 | 16–38 |
| Pulse (beats/min) | 117.02 ± 19.78 | 62–150 |
| Systolic blood pressure (mmHg) | 106.70 ± 22.74 | 67–157 |
| Temp (°C) | 36.07 ± 2.46 | 35–39 |
| White cell count (cells/mL3) | 12.96 ± 8.53 | 3–44 |
| Total Bilirubin (μmol/L) | 16.33 ± 13.83 | 2–70 |
| Creatinine (μmol/L) | 200.3 ± 315.47 | 28–1405 |
| Platelets (109/L) | 289.04 ± 154.05 | 18–734 |
Initial emergency centre management.
| Variable | n (%) |
|---|---|
| Received antibiotics in the EC | 46 (88.5) |
| Ceftriaxone | 28 (56.0) |
| Co-Amoxiclav | 14 (28.0) |
| Cloxacillin | 1 (2.0) |
| Metronidazole | 3 (6.0) |
| Gentamycin | 1 (2.0) |
| Rifafour | 2 (4.0) |
| Cotrimoxazole | 1 (2.0) |
| Time taken to administer antibiotic | |
| 0–1 h | 11 (24.0) |
| 1–2 h | 6 (13.0) |
| >2 h | 7 (15.2) |
| Missing administration time data | 22 (47.8) |
| Cultures performed | 35 (67.3) |
| Blood | 14 (40.0) |
| Sputum | 10 (28.6) |
| Cerebrospinal fluid | 6 (17.1) |
| Swabs | 1(2.8) |
| Urine | 3 (8.6) |
| Pleural fluid | 1(2.8) |
| Cultures positive | 8 (22.9) |
| Staphylococcus species | 2 (25.0) |
| Streptococcus group D | 1 (12.5) |
| Corynebacterium species | 1 (12.5) |
| Proteus species | 1 (12.5) |
| | 3 (37.5) |
| Fluid administered | 30 (57.7) |
| Crystalloid | 17 (56.0) |
| Colloid | 0 |
| Freeze dried plasma | 0 |
| Blood | 0 |
| Not documented | 13 (43.4) |
| Vasopressor/inotropic support | 1 (1.9) |